<p>The past few years have witnessed dramatic advances in computational methods for Bayesian inference. As a result, Bayesian approaches to solving a wide variety of problems in data analysis and decision-making have become feasible, and there is currently a growth spurt in the application of Bayesi
Case Studies in Bayesian Methods for Biopharmaceutical CMC
β Scribed by Paul Faya, Tony Pourmohamad
- Publisher
- CRC Press/Chapman & Hall
- Year
- 2022
- Tongue
- English
- Leaves
- 354
- Series
- Chapman & Hall/CRC Biostatistics Series
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
The subject of this book is applied Bayesian methods for chemistry, manufacturing, and control (CMC) studies in the biopharmaceutical industry. The book has multiple authors from industry and academia, each contributing a case study (chapter). The collection of case studies covers a broad array of CMC topics, including stability analysis, analytical method development, specification setting, process development and optimization, process control, experimental design, dissolution testing, and comparability studies. The analysis of each case study includes a presentation of code and reproducible output. This book is written with an academic level aimed at practicing nonclinical biostatisticians, most of whom have graduate degrees in statistics.
β’ First book of its kind focusing strictly on CMC Bayesian case studies
β’ Case studies with code and output
β’ Representation from several companies across the industry as well as academia
β’ Authors are leading and well-known Bayesian statisticians in the CMC field
β’ Accompanying website with code for reproducibility
β’ Reflective of real-life industry applications/problems
β¦ Table of Contents
Cover
Half Title
Series Page
Title Page
Copyright Page
Dedication
Contents
Foreword
Preface
Contributors
1. Introduction
2. An Overview of Bayesian Computation
3. Basic Bayesian Model Checking
4. Quantitative Decision-Making, a CMC Application to Analytical Method Equivalence
5. Bayesian Dissolution Testing
6. A Non-Normal Bayesian Model for the Estimation and Comparison of Immunogenicity Screening Assay Cut-Points
7. Application of Bayesian Hierarchical Models to Experimental Design
8. Bayesian Prediction for Staged Testing Procedures
9. A Bayesian Approach to Multivariate Conditional Regression Surrogate Modeling with Application to Real Time Release Testing
10. Bayesian Approach for Demonstrating Analytical Similarity
11. Bayesian Evaluation and Monitoring of Process Comparability
12. Bayesian Alternatives to Traditional Methods for Estimating Product Shelf-Life and Internal Release Limits
13. Application of Bayesian Methods for Specification Setting
14. Calculating Statistical Tolerance Intervals Using SAS
15. A Bayesian Application in Process Monitoring β Establishing Limits for Dosage Units in Early Phase Process Control
Bibliography
π SIMILAR VOLUMES
<p>Like its predecessor, this second volume presents detailed applications of Bayesian statistical analysis, each of which emphasizes the scientific context of the problems it attempts to solve. The emphasis of this volume is on biomedical applications. These papers were presented at a workshop at C
<p>Like the first two volumes, this third volume of case studies presents detailed applications of Bayesian statistical analysis, emphasizing the sciΒ entific context. The papers were presented and discussed at a workshop at Carnegie Mellon University, October 5-7, 1995. In this volume, which is ded
<p>The 4th Workshop on Case Studies in Bayesian Statistics was held at the CarΒ negie Mellon University campus on September 27-28, 1997. As in the past, the workshop featured both invited and contributed case studies. The former were presented and discussed in detail while the latter were presented
<p>The 5th Workshop on Case Studies in Bayesian Statistics was held at the Carnegie Mellon University campus on September 24-25, 1999. As in the past, the workshop featured both invited and contributed case studies. The former were presented and discussed in detail while the latter were presented in
<b>The concepts, applications, and practical issues of Quality by Design</b><p><p> Quality by Design (QbD) is a new framework currently being implemented by the FDA, as well as EU and Japanese regulatory agencies, to ensure better understanding of the process so as to yield a consistent and high-qua